Physician profile
Patrick N Rhoades
NPI 1972568400
$5,110.63
in general payments reported to CMS, 2019-2025
37 companies · $280 in 2025
The $280 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,221 · 2020: $575 · 2021: $821 · 2022: $929 · 2023: $540 · 2024: $745 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,412.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $152.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $999.27 | 2019-2022 | |
| Abbvie INC. | $944.05 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $499.00 | 2019-2025 | Xtampza, Belbuca |
| Nevro Corp. | $475.07 | 2020-2024 | Senza |
| Pfizer INC. | $240.22 | 2019-2023 | |
| Horizon Therapeutics Plc | $196.87 | 2019-2020 | |
| Electronic Waveform Lab, INC. | $191.51 | 2019 | |
| Painteq LLC | $159.50 | 2022-2024 | Painteq |
| Neuronetics, INC. | $152.28 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.45 | 2019-2025 | Relistor |
| Forte Bio-Pharma LLC | $108.96 | 2019-2022 | |
| Boston Scientific Corporation | $99.89 | 2019-2024 | Infinion 16 |
| Teva Pharmaceuticals USA, INC. | $87.14 | 2019-2022 | |
| Mdd US Operations, LLC | $69.37 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $66.39 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $61.23 | 2025 | Senza |
| Biohaven Pharmaceuticals, INC. | $60.45 | 2021 | |
| Indivior INC. | $57.69 | 2019-2023 | Sublocade |
| Merz North America, INC. | $54.58 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $41.72 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $38.28 | 2024-2025 | |
| Medtronic, INC. | $38.03 | 2021 | |
| Lilly USA, LLC | $37.38 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Redhill Biopharma INC. | $32.02 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $31.10 | 2019-2021 | |
| Shionogi INC | $30.51 | 2019 | |
| Merz Pharmaceuticals, LLC | $28.19 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $26.91 | 2019 | |
| Medtronic USA, INC. | $25.93 | 2020 | |
| Amgen INC. | $24.69 | 2019 | |
| Lundbeck LLC | $24.47 | 2021 | |
| Scilex Pharmaceuticals INC. | $22.39 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.65 | 2019 | |
| Impel Pharmaceuticals INC. | $15.12 | 2022 | |
| Abbott Laboratories | $14.22 | 2025 | Proclaim |
| Bioventus LLC | $13.57 | 2019 | |
| Si-Bone, INC. | $9.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Rhoades listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.